Photo from wikipedia
There are limited data on vaccine effectiveness (VE) against the Omicron variant in adolescents. In Ontario, Canada, most vaccinated adolescents completed their primary series of BNT162b2 during summer 2021; third… Click to show full abstract
There are limited data on vaccine effectiveness (VE) against the Omicron variant in adolescents. In Ontario, Canada, most vaccinated adolescents completed their primary series of BNT162b2 during summer 2021; third dose eligibility (6 months following a second dose) expanded to those aged 12-17 years in February 2022. We estimated 2-dose and 3-dose VE against Omicron (BA.1/BA.1.1) and Delta for this age group.
Keywords:
effectiveness bnt162b2;
vaccine effectiveness;
omicron;
bnt162b2 delta;
delta omicron
Journal Title: Pediatrics
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Pediatrics
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!